YIN-HSIU CHIENShieh Y.-D.Yang C.-Y.NI-CHUNG LEEWUH-LIANG HWU2020-12-092020-12-0920131096-7192https://www.scopus.com/inward/record.uri?eid=2-s2.0-84878507061&doi=10.1016%2fj.ymgme.2013.04.003&partnerID=40&md5=0d29e188db0dd580692ed5dbeec1e7b1https://scholars.lib.ntu.edu.tw/handle/123456789/525134[SDGs]SDG32 hydroxypropyl beta cyclodextrin; central nervous system disease; drug dose reduction; drug infusion; drug safety; hepatosplenomegaly; human; letter; lung fibrosis; lung toxicity; Niemann Pick disease; nonhuman; pneumonia; priority journal; risk factor; beta-Cyclodextrins; Female; Humans; Niemann-Pick Disease, Type CLung toxicity of hydroxypropyl-β-cyclodextrin infusionletter10.1016/j.ymgme.2013.04.003236115772-s2.0-84878507061